0.1697
Finanzdaten der Processa Pharmaceuticals Inc-Aktie (PCSA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Operating Income/Loss |
38.77%
-3.9508
|
-2.847 | -2.7347 | -3.4249 | -3.082 |
Income/Loss From Continuing Operations Before Tax |
38.79%
-3.9339
|
-2.8344 | -2.7287 | -3.3847 | -3.0103 |
Income/Loss From Continuing Operations After Tax |
38.79%
-3.9339
|
-2.8344 | -2.7287 | -3.3847 | -3.0103 |
|
38.79%
-3.9339
|
-2.8344 | -2.7287 | -3.3847 | -3.0103 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
63.43%
15.57
|
9.5268 | 0.15 | 3.276 | 2.9833 |
Diluted Average Shares |
63.43%
15.57
|
9.5268 | 0.15 | 3.276 | 2.9833 |
Basic Earnings Per Share |
16.67%
-0.25
|
-0.30 | -0.74 | -1.03 | -1.01 |
Diluted Earnings Per Share |
16.67%
-0.25
|
-0.30 | -0.74 | -1.03 | -1.01 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):